Calvert Investment Management’s Boston Scientific BSX Stock Holding History

Calvert Investment Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-85,666	Closed	-$1.85M	–	101
2016 Q4	$1.85M	Sell	85,666 -1,496	-2%	-$32.6K	0.07%	300
2016 Q3	$2.07M	Buy	87,162 +5,445	+7%	+$130K	0.08%	287
2016 Q2	$1.91M	Buy	81,717 +1,026	+1%	+$22.2K	0.08%	263
2016 Q1	$1.52M	Buy	80,691 +17,030	+27%	+$299K	0.07%	255
2015 Q4	$1.17M	Buy	63,661 +15,415	+32%	+$276K	0.05%	279
2015 Q3	$792K	Buy	48,246 +1,006	+2%	+$17.2K	0.04%	266
2015 Q2	$836K	Buy	+47,240	New	+$844K	0.04%	270

Other funds holding BSX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Calvert Investment Management's BSX Position: Q1 2017 in Review

Calvert Investment Management sold out of Boston Scientific (BSX) in Q1 2017, closing a stake of 85,666 shares — an estimated $1.85M sold.

Calvert Investment Management first reported a position in BSX in Q2 2015 and held it in 7 quarters. The position peaked at $2.07M in Q3 2016. 552 funds tracked by Wall St. Rank hold BSX as of Q1 2017.

Calvert Investment Management reported no remaining Boston Scientific position as of Q1 2017 after selling out during the quarter.
Calvert Investment Management sold 85,666 Boston Scientific shares in Q1 2017, an estimated $1.85M.
Calvert Investment Management first reported a position in Boston Scientific in Q2 2015 and held it in 7 quarters.
Calvert Investment Management's Boston Scientific position peaked at $2.07M in Q3 2016.
552 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2017.

Based on Calvert Investment Management's 13F filing for Q1 2017.